{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:40:12Z","timestamp":1788565212516,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16674-2","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T10:00:14Z","timestamp":1755943214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SRCIN1 promotes thyroid carcinoma growth by activating Wnt signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Chunyao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"16674_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"16674_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3322\/caac.21565","volume":"69","author":"KD Miller","year":"2019","unstructured":"Miller, K. D. et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J. Clin. 69, 363\u2013385. https:\/\/doi.org\/10.3322\/caac.21565 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"16674_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3322\/caac.21637","volume":"70","author":"KD Miller","year":"2020","unstructured":"Miller, K. D. et al. Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin 70, 443\u2013459. https:\/\/doi.org\/10.3322\/caac.21637 (2020).","journal-title":"CA Cancer J Clin"},{"key":"16674_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020 (2016).","journal-title":"Thyroid"},{"key":"16674_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"16674_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4143\/crt.2020.206","volume":"52","author":"S Hong","year":"2020","unstructured":"Hong, S. et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2017. Cancer Res. Treat. 52, 335\u2013350. https:\/\/doi.org\/10.4143\/crt.2020.206 (2020).","journal-title":"Cancer Res. Treat."},{"key":"16674_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"16674_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrd3360","volume":"10","author":"M McClellan","year":"2011","unstructured":"McClellan, M. et al. An accelerated pathway for targeted cancer therapies. Nat. Rev. Drug Discov. 10, 79\u201380. https:\/\/doi.org\/10.1038\/nrd3360 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"16674_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/s1470-2045(15)00473-8","volume":"16","author":"M Gore","year":"2015","unstructured":"Gore, M. & Larkin, J. Precision oncology: Where next?. Lancet Oncol. 16, 1593\u20131595. https:\/\/doi.org\/10.1016\/s1470-2045(15)00473-8 (2015).","journal-title":"Lancet Oncol."},{"key":"16674_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","volume":"127","author":"H Clevers","year":"2006","unstructured":"Clevers, H. Wnt\/beta-catenin signaling in development and disease. Cell 127, 469\u2013480. https:\/\/doi.org\/10.1016\/j.cell.2006.10.018 (2006).","journal-title":"Cell"},{"key":"16674_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus, A. & Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8, 387\u2013398. https:\/\/doi.org\/10.1038\/nrc2389 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"16674_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 15, 178\u2013196. https:\/\/doi.org\/10.1038\/nrm3758 (2014).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"16674_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016 (2017).","journal-title":"Cell"},{"key":"16674_CR14","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.febslet.2012.02.037","volume":"586","author":"CH Heldin","year":"2012","unstructured":"Heldin, C. H., Vanlandewijck, M. & Moustakas, A. Regulation of EMT by TGF\u03b2 in cancer. FEBS Lett. 586, 1959\u20131970. https:\/\/doi.org\/10.1016\/j.febslet.2012.02.037 (2012).","journal-title":"FEBS Lett."},{"key":"16674_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1091\/mbc.e03-09-0689","volume":"15","author":"P Di Stefano","year":"2004","unstructured":"Di Stefano, P. et al. P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading. Mol. Biol. Cell 15, 787\u2013800. https:\/\/doi.org\/10.1091\/mbc.e03-09-0689 (2004).","journal-title":"Mol. Biol. Cell"},{"key":"16674_CR16","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1038\/sj.emboj.7601724","volume":"26","author":"P Di Stefano","year":"2007","unstructured":"Di Stefano, P. et al. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. EMBO J. 26, 2843\u20132855. https:\/\/doi.org\/10.1038\/sj.emboj.7601724 (2007).","journal-title":"EMBO J."},{"key":"16674_CR17","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1038\/onc.2010.128","volume":"29","author":"L Damiano","year":"2010","unstructured":"Damiano, L. et al. p140Cap dual regulation of E-cadherin\/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation. Oncogene 29, 3677\u20133690. https:\/\/doi.org\/10.1038\/onc.2010.128 (2010).","journal-title":"Oncogene"},{"key":"16674_CR18","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/ncomms14797","volume":"8","author":"S Grasso","year":"2017","unstructured":"Grasso, S. et al. The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries. Nat. Commun. 8, 14797. https:\/\/doi.org\/10.1038\/ncomms14797 (2017).","journal-title":"Nat. Commun."},{"key":"16674_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/s41418-019-0386-6","volume":"27","author":"S Grasso","year":"2020","unstructured":"Grasso, S. et al. The SRCIN1\/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma. Cell Death Differ. 27, 790\u2013807. https:\/\/doi.org\/10.1038\/s41418-019-0386-6 (2020).","journal-title":"Cell Death Differ."},{"key":"16674_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3892\/ijo.2017.3952","volume":"50","author":"M Zhang","year":"2017","unstructured":"Zhang, M. et al. Overexpression of Srcin1 contributes to the growth and metastasis of colorectal cancer. Int. J. Oncol. 50, 1555\u20131566. https:\/\/doi.org\/10.3892\/ijo.2017.3952 (2017).","journal-title":"Int. J. Oncol."},{"key":"16674_CR21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3892\/etm.2019.7206","volume":"17","author":"Q Lu","year":"2019","unstructured":"Lu, Q., Guo, Z. & Qian, H. Role of microRNA-150-5p\/SRCIN1 axis in the progression of breast cancer. Exp. Ther. Med. 17, 2221\u20132229. https:\/\/doi.org\/10.3892\/etm.2019.7206 (2019).","journal-title":"Exp. Ther. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16674-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16674-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T10:00:15Z","timestamp":1755943215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16674-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16674-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"15 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31024"}}